Cart (0 Items)
Your cart is currently empty.
View ProductsSize | 100ug, 1MG |
---|---|
Isotype | IgG1 |
Brand | ProteoGenix |
Product type | Primary Antibodies |
Clonality | Monoclonal Antibody |
Expression system | Mammalian cells |
Applications | Elisa, WB |
Product name | Adalimumab Biosimilar - Anti-TNF alpha mAb - Research Grade |
---|---|
Source | DrugBank DB00051 |
Species | Human |
Expression system | Mammalian |
Molecular weight | 144kDa |
Purity | >85% |
Buffer | PBS pH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery lead time in business days | 3-5 days if in stock; 3-5 weeks if production needed |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | 4°C for short term; -20°C for long term |
Brand | ProteoGenix |
Aliases /Synonyms | Adalimumab,Adalimumab,TNF alpha,anti-TNF alpha |
Reference | PX-TA1001 |
Note | For research use only. Not suitable for human use. |
Isotype | IgG1 |
Clonality | Monoclonal Antibody |
Adalimumab is a human IgG1 monoclonal antibody that is recombinant and that targets against tumor necrosis factor-alpha (TNF-alpha). This antibody has immunomodulating properties. Adalimumab attaches to TNF-alpha, effectively blocking its interaction with the p55 and p75 TNF cell surface receptors, consequently hindering TNF-mediated immune reactions. TNF-alpha, is an inflammatory cytokine. It is especially involved in autoimmune conditions.
Related products
Send us a message from the form below
Ofer Gover –
We used this ab to reduce as a negative control for reducing caco-2 (IEC) cells exitation by exugenues TNFa. We measured IL8 secreation as a result of TNFa stimulation. 1ug/mL ofAdalimumab Biosimilar – Anti-TNF alpha mAb was enough to completly abolish IL8 secreation by TNFa stimulation in caco-2 cells.